Christopher G. Slatore

Oregon Health & Science University

Papers

1

Total Citations

9

H-Index

1

About

Christopher G. Slatore is a leading researcher in pulmonary and critical care medicine, with a primary focus on patient-centered outcomes in lung cancer care. His work bridges the gap between clinical treatment efficacy and the lived experiences of patients, particularly those with early-stage non–small cell lung cancer who are not candidates for standard lobectomy. Slatore’s major contributions center on comparing the longitudinal quality of life following sublobar resection versus stereotactic body radiation therapy (SBRT), providing critical evidence that helps guide shared decision-making for vulnerable populations. His most-cited paper (2024, 9 citations) is a landmark study that systematically evaluates how these two treatment modalities affect patients’ physical, emotional, and social well-being over time, highlighting the importance of patient-reported outcomes in oncology. This work has already influenced clinical discussions about trade-offs between treatment efficacy and quality of life. Slatore’s research is notable for its rigorous methodology and its commitment to amplifying the patient voice in lung cancer management, making him a key figure in the movement toward more holistic, patient-centered respiratory care.

Research Focus

Key Achievements

1
H-Index
1
Papers
9
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Longitudinal quality of life after sublobar resection and stereotactic body radiation therapy for early‐stage non–small cell lung cancer
9 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Oregon Health & Science University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago